Literature DB >> 25088630

Implantation of 2 trabecular microbypass stents in a patient with primary open-angle glaucoma refractory to previous glaucoma-filtering surgeries.

Kelsey Roelofs1, Sourabh Arora1, Michael W Dorey2.   

Abstract

UNLABELLED: A 77-year-old woman with primary open-angle glaucoma was referred for surgical evaluation after failing to achieve target intraocular pressure (IOP) despite previous combined phacotrabeculectomy and Ahmed valve implantations. The IOP prior to surgery was 28 mm Hg on topical dorzolamide-timolol, latanoprost, and brimonidine. Trabecular bypass surgery with implantation of 2 iStents was performed. The IOP decreased by 11 mm Hg to 17 mm Hg after surgery and has remained stable for 2 years. This is the first published case reporting this magnitude of IOP reduction sustained for more than 2 years following insertion of 2 trabecular microbypass stents in a patient who had previous glaucoma-filtering surgeries. Further prospective studies are needed to establish expanded surgical indications for implantation of trabecular microbypass stents. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2014 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25088630     DOI: 10.1016/j.jcrs.2014.06.017

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

Review 1.  Trabecular micro-bypass shunt (iStent®): basic science, clinical, and future).

Authors:  E Randy Craven
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar

Review 2.  Medical Management of Glaucoma in the 21st Century from a Canadian Perspective.

Authors:  Paul Harasymowycz; Catherine Birt; Patrick Gooi; Lisa Heckler; Cindy Hutnik; Delan Jinapriya; Lesya Shuba; David Yan; Radmila Day
Journal:  J Ophthalmol       Date:  2016-11-08       Impact factor: 1.909

3.  Prospective Evaluation of Two iStent® Trabecular Stents, One iStent Supra® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes.

Authors:  Jonathan S Myers; Imran Masood; Dana M Hornbeak; Jose I Belda; Gerd Auffarth; Anselm Jünemann; Jane Ellen Giamporcaro; Jose M Martinez-de-la-Casa; Iqbal Ike K Ahmed; Lilit Voskanyan; L Jay Katz
Journal:  Adv Ther       Date:  2018-02-23       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.